Retractable Technologies prevails in Becton, Dickinson litigation, shares skyrocket


Make no mistake: It's a good day to be long Retractable Technologies (RVP).

After a protracted legal battle, a jury returned a favorable verdict Thursday in litigation against Becton, Dickinson (BDX).

RVP accused BDX of attempting to monopolize the safety syringe market.

RVP is awarded $113.5M in compensatory damages. (PR)

The market reaction: RVP +141% premarket

Comments (1)
  • doonich
    , contributor
    Comments (10) | Send Message
     
    I own some interesting BD reserved $340mm as it is subject to treble damages. They probably have to per gaap. Not ez to figure out the $/share impact to RVP due to complex capital structure. Lot of $$ though. Hopefully someone can figure it out and post.
    20 Sep 2013, 12:51 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs